Latest News

New drugs offer hope for migraine prevention

Two new studies may offer hope for people with migraines. Both studies involve drugs that are aimed at preventing migraine attacks from occurring, rather than stopping the attacks once they have started. These studies are the first to test monoclonal antibodies for the prevention of migraine, and both are directed against a relatively new target in migraine prevention, the calcitonin gene-related peptide, or CGRP. CGRP has been thought to be important in migraine, but never have drugs been developed to specifically target the protein.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • A bad buzz: Men with HIV need fewer drinks to feel effects

  • Listen to your heart: Why your brain may give away how well you know yourself

  • Mindfulness-based therapy could offer an alternative to antidepressants for preventing depression relapse

  • New guideline advises when to treat a first seizure

  • Extending natalizumab up to 8 weeks shown safe and effective in patients with multiple sclerosis, report says

  • PTSD common in ICU Survivors

  • Frequent indoor tanning among teens shows correlation with smoking, social media use

  • Autism-epilepsy connection explored in four studies

  • Video games in care homes: connecting older adults, or exposing age-related vulnerability?

  • Reducing global tobacco use

  •